Hing Wong
Patrimonio netto: 203 211 $ in data 31/05/2026
Patrimonio netto: 203 211 $ in data 31/05/2026
Hing C.
Wong was the founder of Altor BioScience Corp., founded in 2002, serving as President, Chief Executive Officer & Director from 2012 to 2017.
Dr. Wong was the founder of Sunol Molecular Corp., founded in 1996, serving as Chairman & Chief Executive Officer from 1996 to 2002.
Dr. Wong is the founder of HCW Biologics Inc., founded in 2018, serving as Chief Executive Officer, Secretary & Director since 2018.
Former jobs include Chief Executive Officer at NantCell, Inc. from 2017 to 2018; Director-Biology Skills Center at Baxter International, Inc. from 1992 to 1996; Director-Microbial Genetics Department at Chiron Corp.
from 1983 to 1992; Director-Microbial Genetics at Cetus Corp.
from 1983 to 1992; Director at Biosynexus, Inc.; Trustee at The Cancer Research Foundation, Inc.; and Trustee at Rumbaugh-Goodwin Institute For Cancer Research, Inc. Education includes a doctorate from the University of Massachusetts.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
HCW BIOLOGICS, INC. 1,52% | 22/05/2026 | 102.632 ( 1,52% ) | 203 211 $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| HCW BIOLOGICS INC. | Fondatore | 02/04/2018 |
| Società | Posizione | Fine |
|---|---|---|
NantCell, Inc.
NantCell, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for immunogenic diseases | Amministratore Delegato | 01/03/2018 |
Altor BioScience Corp.
Altor BioScience Corp. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops therapeutic products for the treatment of cancer | Fondatore | 01/08/2017 |
Sunol Molecular Corp.
Sunol Molecular Corp. Pharmaceuticals: MajorHealth Technology Develops gel therapeutics to treat disorders associated with the human tissue factor | Amministratore Delegato | 01/01/2002 |
| BAXTER INTERNATIONAL INC. | Corporate Officer/Principal | 01/01/1996 |
Cetus Corp.
Cetus Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | 01/01/1992 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 11 |
|---|---|
Baxter International, Inc.
Baxter International, Inc. Medical SpecialtiesHealth Technology Produces and supplies medical products, healthcare systems, therapies and pharmaceuticals & provide kidney care services | Health Technology |
Chiron Corp.
Chiron Corp. Medical SpecialtiesHealth Technology Provides nucleic acid test for blood screening | Health Technology |
Altor BioScience Corp.
Altor BioScience Corp. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops therapeutic products for the treatment of cancer | Health Technology |
Cetus Corp.
Cetus Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
University of Massachusetts
University of Massachusetts Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Biosynexus, Inc.
Biosynexus, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products | Health Technology |
Sunol Molecular Corp.
Sunol Molecular Corp. Pharmaceuticals: MajorHealth Technology Develops gel therapeutics to treat disorders associated with the human tissue factor | Health Technology |
The Cancer Research Foundation, Inc.
The Cancer Research Foundation, Inc. Hospital/Nursing ManagementHealth Services Provides cancer treatment services | Health Services |
Rumbaugh-Goodwin Institute For Cancer Research, Inc. | |
NantCell, Inc.
NantCell, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for immunogenic diseases | Health Technology |
HCW Biologics Inc.
HCW Biologics Inc. BiotechnologyHealth Technology Develops immunotherapies for chronic, low-grade inflammation and age related disorders | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale